Santen Pharmaceutical Co(MX:4536N)
MX$250.000.00 (0.00%)
MX:4536N
Santen Pharmaceutical Co earnings date
MX$250.00
At close:0.00 (0.00%)
Santen Pharmaceutical Co (4536N) Q2 2026 Earnings Report
0 Followers
MX:4536N Q2 2026 EPS Results
- Actual EPS
- MXN 3.01
- Consensus EPS
- MXN 3.66
- Beat/Miss
- Missed by -MXN 0.65
- One Year Ago EPS
- MXN 2.86
MX:4536N Q2 2026 Revenue Results
- Actual Revenue
- MXN 8.71B
- Expected Revenue
- MXN 8.53B
- Beat/Miss
- Beat by +MXN 179.98M
- YoY Revenue Growth
- +7.51%
Earnings Announcement Details
- Quarter
- Q2 2026
- Date
- 11/05/2026
- Time
- TBA
- Conference Call
- Thursday, November 5, 2026
MX:4536N Upcoming Earnings
Santen Pharmaceutical Co's next earnings date is estimated for February 9, 2027, based on past reporting schedules.
Q2 2026 Earnings Call Audio
MX:4536N Q2 2026 Earnings Call
0:00 / 0:00
Q2 2026 Earnings Slide Deck
Q2 2026 Earnings Call Summary
No earnings call summary is available for this earnings event.
MX:4536N Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 09, 2027 | 2026 (Q3) | 4.41- | 2.86 | ― | ― |
| Nov 05, 2026 | 2026 (Q2) | 3.663.01 | 2.86 | 5.03% (+0.14) | |
| Aug 06, 2026 | 2026 (Q1) | 2.492.62 | 2.03 | 29.21% (+0.59) | |
| May 12, 2026 | 2025 (Q4) | 3.615.61 | 3.02 | 85.80% (+2.59) | |
| Feb 05, 2026 | 2025 (Q3) | 3.432.86 | 2.97 | -3.67% (-0.11) | |
| Nov 06, 2025 | 2025 (Q2) | 2.452.86 | 2.73 | 4.94% (+0.13) | |
| Aug 07, 2025 | 2025 (Q1) | 2.802.03 | 3.47 | -41.47% (-1.44) | |
| May 13, 2025 | 2024 (Q4) | 2.033.02 | 1.92 | 57.30% (+1.10) | |
| Feb 06, 2025 | 2024 (Q3) | 3.062.97 | 2.37 | 25.40% (+0.60) | |
| Nov 07, 2024 | 2024 (Q2) | 2.542.73 | 2.83 | -3.48% (-0.10) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
